Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

EGLN1 Rabbit anti-Human, Polyclonal Antibody, Abnova™

Catalog No. 89115815 Shop All Abnova Corporation Products
Change view
Click to view available options
Quantity:
100 μL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
89-115-815 100 μL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 89-115-815 Supplier Abnova Corporation Supplier No. PAB12440
Add to Cart
Add to Cart

Rabbit polyclonal antibody raised against synthetic peptide of EGLN1.

Specifications

Antigen EGLN1
Applications Immunohistochemistry, Immunoprecipitation, Western Blot
Classification Polyclonal
Conjugate Unconjugated
Description Rabbit polyclonal antibody raised against synthetic peptide of EGLN1.
Dilution The optimal working dilution should be determined by the end user.
Formulation In Tris-citrate/phosphate buffer, pH 7.0-8.0 (0.09% sodium azide)
Gene EGLN1
Gene Accession No. Q9GZT9
Gene Alias C1orf12/DKFZp761F179/ECYT3/HIFPH2/HPH2/PHD2/SM-20/SM20/ZMYND6
Gene Symbols EGLN1
Host Species Rabbit
Immunogen A synthetic peptide corresponding to amino acids 350-426 of human EGLN1.
Quantity 100 μL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 54583
Test Specificity This antibody is specific to human HIF prolyl hydroxylase 2. There is 83% homology between the immunogen used for this antibody and the rat and mouse proteins.
Target Species Human
Content And Storage Store at 4°C. Do not freeze.
Form Liquid
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.